Allergies, Anemia, Antibiotic Use, Blood Pressure, Breastfeeding, Breastfeeding Continuation, Breastfeeding Duration, Breastfeeding Education, Child Development, Child Growth, Coughing, Diarrhea, Eczema, Infectious Diseases, Mental Health, Stress, Weight Loss
Conditions
Keywords
breastfeeding, cash transfer, child health, maternal health, mental health, child growth, child development, education
Brief summary
The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are: * Does the social transfer increase complementary breastfeeding rates at 24-months postpartum? * Does the social transfer increase complementary breastfeeding duration? * Does the social transfer impact child health and development? * Does the social transfer impact maternal physical and mental health? Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding. Participants will: Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire
Interventions
OTHERSocial Transfer
A social transfer will be given conditioned upon breastfeeding at 24-months postpartum.
Sponsors
Swiss Tropical & Public Health Institute
Centre Suisse de Recherches Scientifique en Côte d'Ivoire
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
12 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Are enrolled in the Taabo multigenerational birth cohort (MGC) 2. Completed the postpartum interview of the Taabo MGC 3. Have a child who is within two weeks of their 12-month birthday, 4. are breastfeeding at time of recruitment, 5. live in the Taabo HDSS, Côte d'Ivoire 6. have no illnesses that contraindicates breastfeeding, 7. had a healthy singleton infant with a birth weight of at least 2500 grams, and 8. agree to participate and sign an informed consent; if underage (12-17 years), a legal representative will also have to agree to sign the informed consent
Exclusion criteria
1. Plans to move permanently outside study area 2. Has a medical, intellectual or psychological disability 3. Contraindication for breastfeeding 4. Children born with \< 2500 grams
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of Complementary Breastfeeding | from 12 to 24 months postpartum | Prevalence of complementary breastfeeding at 24 months postpartum. |
| Complementary Breastfeeding Duration | from 12 to 24 months postpartum | Duration of complementary breastfeeding in weeks. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Weight-for-Age z-score | 12 months; 24 months | Infants will be weighed in kilograms by a mobile weighing scale. Measurements will be analyzed as age standardized z-scores. |
| Child Health Outcomes | 12 months; 24 months | We will assess the child's health outcomes by using a questionnaire administered to the caregiver. The questionnaire will ask a range of yes or no questions about child diarrhea, respiratory illness, fever, and child antibiotic use. |
| Percent weight loss | 12 months; 24 months; | Percent weight loss will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Percent weight loss will be calculated as ((current weight - pregnancy weight) / pregnancy weight) × 100. |
| Mother and Child Hemoglobin Levels | 12 months; 24 months | We will assess the mother and child anemia levels. The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Iron levels will be analyzed as a continuous outcome. |
| Maternal Depression | 12 months; 24 months | Maternal postpartum depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9); categorized as a binary: no depression (score \<10) or depression present (score ≥10). |
| Height-for-age z-score | 12 months; 24 months | Height will be measured in centimeters by using a Height Measuring Device, stadiometer, 20-205cm. All measurements will be analyzed as age standardized z-scores |
| Mid-upper arm circumference (MUAC) | 12 months; 24 months | Infants will be measured for mid-upper arm circumference (MUAC) using non-stretchable measuring tape. All measurements will be analyzed as age standardized z-scores. |
| Mother and Child Anemia | 12 months; 24 months | The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Hemoglobin levels (gm/dL) will be used to categorize mothers and children into a binary variable: anemic or not anemic. |
| Maternal weight change | 12 months; 24 months; | Weight weight change will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Maternal weight change will be calculated as the difference between postpartum weight and pregnancy weight. Because pregnancy weight varies by gestational age, analyses will control for gestational age at pregnancy weight measurement and time postpartum at outcome measurement. Categorized as: no weight loss (0 kg); moderate weight loss (\<0 to \>-5 kg); high weight loss (≥-5 kg); moderate weight gain (\>0 to \<5 kg); high weight gain (≥5 kg). |
| Change in systolic and diastolic blood pressure (mmHg) | 12 months; 24 months; | Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be categorized as low, normal, or high according to standard clinical thresholds. |
| Caregiver Reported Early Development Instruments (CREDI) cognitive z-score | 12 months; 24 months | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. |
| CREDI language z-score | 12 months; 24 months | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. |
| CREDI motor z-score | 12 months; 24 months | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. |
| CREDI social-emotional z-score | 12 months; 24 months | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. |
| Maternal Anxiety | 12 months; 24 months | Maternal postpartum anziety will be assessed using the the GAD-7 (Generalized Anxiety Disorder-7); a seven-item self-report questionnaire designed to measure the severity of anxiety; categorized as: Minimal Anxiety: score 0-4; Mild Anxiety: score 5-9; Moderate Anxiety: score 10-14; Severe Anxiety: score 15-21 |
Countries
Côte d’Ivoire
Outcome results
None listed